Evidence mapPaperPMID 41398124Full record

ReviewLasers in medical science2025

Therapeutic mechanisms and applications of 808 nm laser irradiation: from wound healing to neurological recovery - a review.

Mojan Imani

Abstract readReview
PubMed Publisher
In one paragraph

Review in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mojan ImaniIndependent Researcher, Tehran, Islamic Republic of Iran. imani.mozhan@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 808-nm wavelength laser has emerged as a promising non-invasive tool with significant therapeutic potential in various medical fields. This review highlights its biological mechanisms, including anti-inflammatory effects, tissue repair, and pain modulation. The laser inhibits the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, reducing pro-inflammatory cytokines (e.g., tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)) and increasing interleukin-10 (IL-10), an anti-inflammatory mediator that accelerates healing. The laser also activates the transforming growth factor-beta (TGF-β) pathway to stimulate collagen synthesis and fibroblast activity, enhancing tissue regeneration. Additionally, by promoting vascular endothelial growth factor (VEGF) expression, and improves neovascularization and tissue oxygenation as well. The modulation of transient receptor potential vanilloid 1 (TRPV1) channels, increased adenosine triphosphate (ATP) production, and activation of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) and the brain-derived neurotrophic factor (BDNF) pathways further support neuroprotection and cellular recovery. Importantly, recent insights suggest the laser's interaction with glial cells particularly astrocytes and microglia plays a critical role in managing neuro-inflammation and improving outcomes in neurological disorders such as hydrocephalus. The ability to influence cerebrospinal fluid regulation and enhance brain barrier permeability positions the 808-nm laser as a potential therapeutic option for improving life quality in affected individuals. Despite its potential, further clinical studies are required to validate and standardize its application across medical protocols.

Indexed as

Low-Level Light TherapyWound HealingAnimalsHumansTRPV Cation ChannelsTRPV Cation Channels808 nm diode laserInflammation reductionLow-level laser therapy (LLLT)PhotobiomodulationTissue repair

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.